GLOBAL औषधम् PORTFOLIO
Healing Compounds for Worldwide Health
DRIVE DOUBLE DIGIT GROWTH through Innovation
OUR API PORTFOLIO
Each product embodies our commitment to quality, precision, and global health impact
Atorvastatin Calcium
Cardiovascular Health - Hridaya Protection
HMG-CoA reductase inhibitor for cholesterol management
- Specifications
• USP/BP/EP Standards
• 10mg-80mg Range
• Crystalline Form I
- Regulatory Status
FDA DMF
EMA CEP
WHO-PQ
Telmisartan
Cardiovascular Health - Hridaya Protection
Angiotensin II receptor antagonist for hypertension
- Specifications
• USP/BP/EP Standards
• 20mg-80mg Range
• Polymorphic Control
- Regulatory Status
FDA DMF Applied
EMA CEP
Multiple Approvals
Metformin HCl
Metabolic Disorders - Agni Balance
Biguanide antidiabetic for Type 2 diabetes management
- Specifications
• USP/BP/EP Standards
• 500mg-1000mg
• IR/SR Formulations
- Regulatory Status
FDA Approved
EMA Approved
WHO-PQ Listed
Sitagliptin Phosphate
Metabolic Disorders - Agni Balance
DPP-4 inhibitor for glucose control
- Specifications
• USP Standards
• 25mg-100mg Range
• Monohydrate Form
- Regulatory Status
FDA DMF
Development Stage
Patent Considerations
Escitalopram Oxalate
Neurological Health - Majja Dhatu Support
SSRI antidepressant for mood disorders
- Specifications
• USP/BP/EP Standards
• 5mg-20mg Range
• Oxalate Salt
- Regulatory Status
FDA DMF Active
EMA Approved
Global Supply
Levetiracetam
Neurological Health - Majja Dhatu Support
Antiepileptic drug for seizure management
- Specifications
• USP/BP/EP Standards
• 250mg-1000mg
• IR/XR Formulations
- Regulatory Status
FDA DMF Applied
EMA CEP
WHO-PQ Active
Montelukast Sodium
Respiratory Care - Prana Vaha Srotas
Leukotriene receptor antagonist for asthma
- Specifications
• USP/BP/EP Standards
• 4mg-10mg Range
• Chewable/Tablet
- Regulatory Status
FDA DMF
EMA Filed
Pediatric Approvals
Azithromycin Dihydrate
Anti-Infective Solutions - Ojas Protection
Macrolide antibiotic for bacterial infections
- Specifications
• USP/BP/EP Standards
• 250mg-500mg
• Dihydrate Form
- Regulatory Status
FDA Approved
EMA CEP Active
WHO-PQ Listed
PORTFOLIO COMPANIES
Specialized subsidiaries driving innovation across pharmaceutical sectors
CHIERON
Complex Generics & Drug Delivery Innovation
Key Capabilities:
• Difficult-to-synthesize molecules
• Novel drug delivery systems
• Sustained-release formulations
• Combination products
Focus Products:
• Controlled-release cardiovascular APIs
• Extended-release CNS medications
• Targeted oncology compounds
GLOCHEM INDIA
Specialty Chemicals & Green Chemistry
Focus Areas:
• Plant-derived pharmaceutical intermediates
• Sustainable synthesis pathways
• Green chemistry applications
• Custom manufacturing services
Technologies:
• Biotransformation processes
• Enzyme-catalyzed reactions
• Continuous flow chemistry
QUALITY EXCELLENCE
Global regulatory compliance and quality leadership
15+
DMF Filings
FDA
Approved Facility
WHO-PQ
Prequalified
EMA
CEP Certified